Incyte Statistics
Total Valuation
Incyte has a market cap or net worth of $13.69 billion. The enterprise value is $11.95 billion.
| Market Cap | 13.69B |
| Enterprise Value | 11.95B |
Important Dates
The last earnings date was Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Incyte has 192.65 million shares outstanding. The number of shares has decreased by -4.49% in one year.
| Current Share Class | 192.65M |
| Shares Outstanding | 192.65M |
| Shares Change (YoY) | -4.49% |
| Shares Change (QoQ) | -10.24% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 81.31% |
| Float | 160.50M |
Valuation Ratios
The trailing PE ratio is 478.81 and the forward PE ratio is 12.52. Incyte's PEG ratio is 0.50.
| PE Ratio | 478.81 |
| Forward PE | 12.52 |
| PS Ratio | 3.75 |
| Forward PS | 2.96 |
| PB Ratio | 4.32 |
| P/TBV Ratio | 4.73 |
| P/FCF Ratio | 445.83 |
| P/OCF Ratio | 134.39 |
| PEG Ratio | 0.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 148.46, with an EV/FCF ratio of 389.21.
| EV / Earnings | 367.88 |
| EV / Sales | 2.93 |
| EV / EBITDA | 148.46 |
| EV / EBIT | n/a |
| EV / FCF | 389.21 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.87 |
| Quick Ratio | 1.69 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.19 |
| Interest Coverage | -4.23 |
Financial Efficiency
Return on equity (ROE) is 0.80% and return on invested capital (ROIC) is -0.17%.
| Return on Equity (ROE) | 0.80% |
| Return on Assets (ROA) | -0.12% |
| Return on Capital (ROIC) | -0.17% |
| Revenue Per Employee | $1.61M |
| Profits Per Employee | $12,869 |
| Employee Count | 2,524 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 45.13 |
Taxes
In the past 12 months, Incyte has paid $241.38 million in taxes.
| Income Tax | 241.38M |
| Effective Tax Rate | 88.14% |
Stock Price Statistics
The stock price has increased by +30.92% in the last 52 weeks. The beta is 0.71, so Incyte's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +30.92% |
| 50-Day Moving Average | 69.59 |
| 200-Day Moving Average | 61.98 |
| Relative Strength Index (RSI) | 43.55 |
| Average Volume (20 Days) | 2,780,734 |
Short Selling Information
The latest short interest is 7.42 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 7.42M |
| Short Previous Month | 7.35M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 4.98 |
Income Statement
In the last 12 months, Incyte had revenue of $4.08 billion and earned $32.48 million in profits. Earnings per share was $0.15.
| Revenue | 4.08B |
| Gross Profit | 1.20B |
| Operating Income | -11.29M |
| Pretax Income | 351.14M |
| Net Income | 32.48M |
| EBITDA | 80.49M |
| EBIT | -11.29M |
| Earnings Per Share (EPS) | $0.15 |
Balance Sheet
The company has $1.77 billion in cash and $36.51 million in debt, giving a net cash position of $1.74 billion or $9.02 per share.
| Cash & Cash Equivalents | 1.77B |
| Total Debt | 36.51M |
| Net Cash | 1.74B |
| Net Cash Per Share | $9.02 |
| Equity (Book Value) | 3.17B |
| Book Value Per Share | 16.45 |
| Working Capital | 1.31B |
Cash Flow
In the last 12 months, operating cash flow was $101.85 million and capital expenditures -$71.15 million, giving a free cash flow of $30.70 million.
| Operating Cash Flow | 101.85M |
| Capital Expenditures | -71.15M |
| Free Cash Flow | 30.70M |
| FCF Per Share | $0.16 |
Margins
Gross margin is 29.33%, with operating and profit margins of -0.28% and 0.80%.
| Gross Margin | 29.33% |
| Operating Margin | -0.28% |
| Pretax Margin | 6.72% |
| Profit Margin | 0.80% |
| EBITDA Margin | 1.97% |
| EBIT Margin | -0.28% |
| FCF Margin | -3.58% |
Dividends & Yields
Incyte does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.49% |
| Shareholder Yield | 4.49% |
| Earnings Yield | 0.24% |
| FCF Yield | 0.22% |
Analyst Forecast
The average price target for Incyte is $75.47, which is 6.22% higher than the current price. The consensus rating is "Buy".
| Price Target | $75.47 |
| Price Target Difference | 6.22% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 9.13% |
| EPS Growth Forecast (5Y) | 24.77% |
Stock Splits
The last stock split was on September 1, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 1, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Incyte has an Altman Z-Score of 4.98 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.98 |
| Piotroski F-Score | 4 |